FRIDAY, Sept. 27, 2024 (HealthDay News) -- The first new type of medication in decades to help fight against schizophrenia ...

Shares in Bristol-Myers Squibb (BMY) surged Friday, after the Food and Drug Administration approved the drugmaker's novel ...

Alembic Pharmaceuticals receives FDA approval for Paliperidone Tablets, trading at ₹1,179.95 on NSE, expanding its global ...

Establishment Labs Holdings shares jumped nearly 30% in premarket trading Friday after the medical-technology company won Food and Drug Administration approval for its Motiva breast implants.

The gene therapy comes seven years after another research group at the university helped come up with the first FDA approved gene therapy for an inherited disease.

Paliperidone extended-release tablets, 1.5 mg, 3 mg, 6 mg, and 9 mg have an estimated market size of $48 million for 12 ...

Alembic Pharmaceuticals receives USFDA approval for its generic version of Paliperidone extended-release tablets, indicated ...

Bristol-Myers Squibb won Food and Drug Administration approval late Thursday for its novel schizophrenia drug, Cobenfy. BMY ...

A popular podcast mentioned it earlier this year, sources say, but the FDA suggests users should be aware of unlisted ingredients.

Bristol Myers surges after the FDA approves an oral medication for schizophrenia in adults, fiscal fourth-quarter revenue at ...

Mumbai: Sun Pharmaceutical Industries Limited has announced that it will present abstracts across its dermatology portfolio ...

Scientists comment on the FDA approving Cobenfy (KarXT) for schizophrenia. Dr Sameer Jauhar, Senior Clinical Lecturer in Affective Disorders and Psychosis, Consultant Psychiatrist, King’s College, ...